# Mesenchymal Stromal

Principales episodios de podcast
Actualizado:

Dominique Farge on allogeneic umbilical cord-derived mesenchymal stromal cells for systemic lupus erythematosus

This is the second episode of a mini series on cell-based therapies in rheumatology, with Prof. Dominique Farge discussing the use of allogeneic umbilical cord-derived mesenchymal stromal cells (MSCs) as treatment for systemic lupus erythematosus (SLE).  We cover the limited options currently avai…

Mesenchymal stromal cells: a potential new SLE treatment option?

Duane Peters from the Lupus Foundation of America interviews Dr Gary Gilkeson from the Medical University of South Carolina about a phase I trial into the use of mesenchymal stromal cells (MSC) in refractory lupus patients in the USA, following impressive results of clinical improvement resulting f…

180: How Mesenchymal Stromal Cells Are Transforming Care for Diabetes and Autoimmune Diseases with Lindsay Davies - Part 2

The promise of advanced cell therapies is undeniable, but as demand skyrockets, the challenges of taking a living drug from bench to bedside have never been greater. Each batch brings variability, each jurisdiction adds regulatory hurdles, and every strategic decision can determine whether a lifesa…

179: How Mesenchymal Stromal Cells Are Transforming Care for Diabetes and Autoimmune Diseases with Lindsay Davies - Part 1

The key to conquering autoimmune diseases and type 1 diabetes may lie not in replacing lost cells, but in retraining the immune system using cells already within the body. Biotech is increasingly exploring stem cell therapies, but a quieter revolution is brewing: stromal cell therapy. These master …

Mesenchymal stromal cells in SCD, CAR T-cell-mediated hematotoxicity in B-cell lymphoma, and dual cytokine blockade in GVHD

In this week’s episode, we’ll talk about the functional properties of mesenchymal stromal cells in sickle cell disease, learn more about CAR T-cell-mediated hematotoxicity in relapsed/refractory B-cell lymphoma, and discuss dual cytokine blockade in graft-versus-host disease.

An Off-the-Shelf Cell Therapy to Calm Cytokine Storms

Small molecule drugs and monoclonal antibodies often fall short at addressing severe inflammatory and immune‑mediated diseases. Mesoblast has spent more than 15 years industrializing mesenchymal stromal cell therapies to treat these conditions. In late 2024, it won U.S. Food and Drug Administration…

Episode 63: LC-MS Metabolomics and Next-Generation Ionization Technologies #chromatography #massspectrometry

In this episode of  @ChromatographyTalk , David speaks with Joseph Corstvet from the Fernandez Lab at Georgia Tech about the future of mass spectrometry, LC-MS metabolomics, and the development of low-cost ionization technologies.Joe discusses his work using LC-MS lipidomics to monitor mesenchymal …

S3:E1 All the answers on stem cells for OA management

Stem cells are an evolving and promising option for osteoarthritis management in dogs and cats. In this podcast we talk to Dr Russell Chandler from Greenside Referrals in Scotland with all the questions you may have about stem cells. We start from the view of the vet in the consulting room with an …

Stem Cell Therapy for Cats: The Next Big Thing? with Dr. Rebecca Windsor

Can stem cell therapy transform the future of feline medicine? In this special Purr Podcast episode, recorded at the AVMA Convention 2026, Dr. Susan Little and Dr. Jolle Kirpensteijn sit down with veterinary neurologist Dr. Rebecca Windsor, to examine one of the most exciting developments in veteri…

Menstrual Blood has stem cells like bone marrow named: Mesenchymal Stromal (MSCs)

#namehim #metoo  #clancy #cornell  🎙️ Commentary • Conversations • Stories • Culture #AlphaSecretClub #InternetCulture #SocialTrends #GenderDynamics #CareerAndAmbition #TrueStories #CulturalDebates #SocialCommentary #culturecommentary #4b  Subscribe and join the book & podcast club  Plus FREE resou…